98 related articles for article (PubMed ID: 10843221)
1. Examination of N-hydroxylation as a prerequisite mechanism of nitric oxide synthase inactivation.
Maurer TS; Pan J; Booth BP; Kalman TI; Fung HL
Bioorg Med Chem Lett; 2000 May; 10(10):1077-80. PubMed ID: 10843221
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines.
Bretscher LE; Li H; Poulos TL; Griffith OW
J Biol Chem; 2003 Nov; 278(47):46789-97. PubMed ID: 12960153
[TBL] [Abstract][Full Text] [Related]
5. Influence of different classes of NO synthase inhibitors in the pig gastric fundus.
Dick JM; Lefebvre RA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):488-94. PubMed ID: 9349636
[TBL] [Abstract][Full Text] [Related]
6. L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.
Moore WM; Webber RK; Jerome GM; Tjoeng FS; Misko TP; Currie MG
J Med Chem; 1994 Nov; 37(23):3886-8. PubMed ID: 7525961
[TBL] [Abstract][Full Text] [Related]
7. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
Babu BR; Griffith OW
J Biol Chem; 1998 Apr; 273(15):8882-9. PubMed ID: 9535869
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective inhibitors of nitric oxide synthesis on the course of experimental hemorrhagic shock.
Remizova MI; Gerbut KA; Kochetygov NI
Bull Exp Biol Med; 2010 Oct; 149(5):571-4. PubMed ID: 21165389
[TBL] [Abstract][Full Text] [Related]
11. Conformationally constrained NO synthase inhibitors: rigid analogs of L-N-iminoethylornithine.
Eustache J; Grob A; Lam C; Sellier O; Schulz G
Bioorg Med Chem Lett; 1998 Nov; 8(21):2961-6. PubMed ID: 9873655
[TBL] [Abstract][Full Text] [Related]
12. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Cooper GR; Barr A; Wolff DJ
Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine.
Young RJ; Beams RM; Carter K; Clark HA; Coe DM; Chambers CL; Davies PI; Dawson J; Drysdale MJ; Franzman KW; French C; Hodgson ST; Hodson HF; Kleanthous S; Rider P; Sanders D; Sawyer DA; Scott KJ; Shearer BG; Stocker R; Smith S; Tackley MC; Knowles RG
Bioorg Med Chem Lett; 2000 Mar; 10(6):597-600. PubMed ID: 10741561
[TBL] [Abstract][Full Text] [Related]
14. L-N6-(1-iminoethyl)-lysine (L-NIL) but not S-methylisothiourea sulphate (SMT) displays selectivity towards NOS-2.
Chłopicki S; Olszanecki R; Jakubowski A; Lomnicka M; Gryglewski RJ
Pol J Pharmacol; 1999; 51(5):443-7. PubMed ID: 10817546
[TBL] [Abstract][Full Text] [Related]
15. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.
Li H; Raman CS; Martásek P; Masters BS; Poulos TL
Biochemistry; 2001 May; 40(18):5399-406. PubMed ID: 11331003
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
Bryk R; Wolff DJ
Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer.
Gao Y; Zhou S; Xu Y; Sheng S; Qian SY; Huo X
Nitric Oxide; 2019 Feb; 83():33-39. PubMed ID: 30590117
[TBL] [Abstract][Full Text] [Related]
18. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS
Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435
[TBL] [Abstract][Full Text] [Related]
19. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
Bryk R; Lubeskie A; Wolff DJ
Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
[TBL] [Abstract][Full Text] [Related]
20. Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats.
Presle N; Cipolletta C; Jouzeau JY; Abid A; Netter P; Terlain B
Arthritis Rheum; 1999 Oct; 42(10):2094-102. PubMed ID: 10524680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
